Glucagon-like peptide-1 receptor agonists (GLP-1RAs), initially developed for T2DM, exert both metabolic and anti-inflammatory effects, which may offer therapeutic benefits for psoriatic disease, particularly in the early stages of PsA
The trial followed more than 300 participants for up to 64 weeks, and Whartons team saw, on average, a nearly 14 percent drop in body weight among people taking the drug
Q: Can I stop the medication once I reach my goal weight
How much water should I drink while on GLP-1 medications
Either way, training with intention helps, and small strength gains still matter for how you look, feel, and move
Page 1 of 2 Page 2: JANUVIA and metformin INSUFFICIENT